Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders

  • Post author:
  • Post published:May 20, 2025
  • Post category:

One in every ten thousand people in the USA have Huntington's Disease, and it impacts many more. Multiple generations within a family can inherit the disease, resulting in escalating health…

Continue ReadingSustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders

Inactivating NK cell reactivity to facilitate transplantation of stem cell derived tissue

  • Post author:
  • Post published:May 20, 2025
  • Post category:

One of the great promises of stem cell research is that it will one day be possible to prepare replacement cells or organs from stem cells such as embryonic stem…

Continue ReadingInactivating NK cell reactivity to facilitate transplantation of stem cell derived tissue

Engineering Embryonic Stem Cell Allografts for Operational Tolerance

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Stem cells, like all transplants not derived from an identical twin, are subject to scrutiny by the immune system and, without medical interventions that suppress the immune system, are usually…

Continue ReadingEngineering Embryonic Stem Cell Allografts for Operational Tolerance

Generation of regulatory T cells by reprogramming

  • Post author:
  • Post published:May 20, 2025
  • Post category:

The goal of our research is to develop efficient methods for making a particular class of immune-system cells known as regulatory T cells (Tregs). Tregs have the potential to be…

Continue ReadingGeneration of regulatory T cells by reprogramming

Mechanism of Tissue Engineered Small Intestine Formation

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Short Bowel Syndrome is an expensive, morbid condition with an increasing incidence. Fundamental congenital and perinatal conditions such as gastroschisis, malrotation, atresia, and necrotizing enterocolitis (NEC) may lead to short…

Continue ReadingMechanism of Tissue Engineered Small Intestine Formation

Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype

  • Post author:
  • Post published:May 20, 2025
  • Post category:

This is an unprecedented time in stem cell biology and regenerative medicine. Today, we have cell lines and tools that did not exist just a few years ago. Indeed, human…

Continue ReadingDerivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype

Stem Cell Gene Therapy for Sickle Cell Disease

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Sickle cell disease (SCD), which results from an inherited mutation in the hemoglobin gene that causes red blood cells to "sickle" under conditions of low oxygen, occurs with a frequency…

Continue ReadingStem Cell Gene Therapy for Sickle Cell Disease

HPSC based therapy for HIV disease using RNAi to CCR5.

  • Post author:
  • Post published:May 20, 2025
  • Post category:

RNA interference is a naturally occurring means to block the function of genes in our body. We propose that RNA interference can be used to block HIV-1 infection and its…

Continue ReadingHPSC based therapy for HIV disease using RNAi to CCR5.

Autologous cardiac-derived cells for advanced ischemic cardiomyopathy

  • Post author:
  • Post published:May 20, 2025
  • Post category:

The adult human heart contains small numbers of cardiac stem cells that are able to partially repair the heart following a heart attack or throughout the course of progressive heart…

Continue ReadingAutologous cardiac-derived cells for advanced ischemic cardiomyopathy

Stem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM)

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Brain tumors (BTs) are incurable, whether they start in the brain or spread there from other sites. Despite advances in surgical, radiation, pharmacologic, and gene therapies, survival with a BT…

Continue ReadingStem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM)
  • Go to the previous page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us